Results 101 to 110 of about 519,396 (228)

Evolving Trends and Drug Class Dynamics in Drug‐Induced Myocarditis: A 2‐Decade Comparative Analysis of Pharmacovigilance Data

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Drug‐induced myocarditis has emerged as an increasingly significant concern with both established and novel medications. This study aimed to identify temporal trends and high‐risk populations in drug‐induced myocarditis through cross ...
Linping Si, Haoyang Xiang, Qingyuan Zhang, Shengyang Xiao, Haitao Yuan   +4 more
doaj   +1 more source

Disproportionality analysis of satralizumab in FDA adverse event reporting system and Japanese adverse drug event report: a pharmacovigilance study

Frontiers in Immunology
BackgroundTo date, no post-marketing safety studies of satralizumab have been conducted. This study aims to evaluate the post-marketing safety profile of satralizumab using data from the U.S.
Linhai Zhang, Linhai Zhang, Rong Yan, Rong Yan, Zucai Xu, Zucai Xu   +5 more
doaj   +1 more source

Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)

, 2020
Roger Yu, Matthew S. Krantz, Elizabeth J. Phillips, Cosby A. Stone   +3 more
openalex   +2 more sources

Safety assessment of ripretinib: a real-world adverse event analysis from the food and drug administration adverse event reporting system

Frontiers in Oncology
BackgroundRipretinib has been approved for the treatment of gastrointestinal stromal tumors (GIST). As a novel therapy, several adverse reactions remain unidentified, necessitating a thorough safety evaluation.
Sentai Wang, Hewen Chen, Yuying Zhou, Jianfeng Chen, Jiwei Cao   +4 more
doaj   +1 more source

Automatically Discovering, Reporting and Reproducing Android Application Crashes

, 2017
Mobile developers face unique challenges when detecting and reporting crashes in apps due to their prevailing GUI event-driven nature and additional sources of inputs (e.g., sensor readings).
Bernal-Cárdenas, Carlos, Linares-Vásquez, Mario, Moran, Kevin, Poshyvanyk, Denys, Vendome, Christopher   +4 more
core   +1 more source

Pharmacovigilance of obeticholic acid: An analysis of the Food and Drug Administration Adverse Event Reporting System database [PDF]

Qining He, Mengting Jiang, Yuchen Wang, Tao Zheng   +3 more
openalex   +1 more source

Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS) [PDF]

Sidi He, Bin Chen, Chuanwei Li
openalex   +1 more source

Disproportionality Measures Used in Signal Detection: An Assessment on Pharmacovigilance Adverse Event Reporting System Data [PDF]

, 2015
G Quattrini, Antonella Zambon, L Simoni, Giancarla Fiori   +3 more
openalex   +1 more source

Adverse Drug Event Reporting System [PDF]

, 2020
openaire   +1 more source

A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database [PDF]

Yuichi Uwai, Tomohiro Nabekura
openalex   +1 more source